CIK 0001951222 · Non-accelerated filer<br>Emerging growth company
SEALSQ Corp
Sign in to watch- Ticker
- LAES
- Exchange
- Nasdaq
- Industry
- Semiconductors & Related Devices
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- other
- Phone
- 212-336-2039
- Business address
- AVENUE LOUIS-CASAI 58, COINTRIN, Switzerland, 1216
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $170,294
- in 3 filings, $170K under 10b5-1 plans
Net −$170,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-29 | Moreira Carlos Chief Executive Officer | Sale 10b5-1 | −10,000 | $3.51 | $35K | 713,520 |
| 2026-05-27 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −4,689 | $3.50 | $16K | 276,156 |
| 2026-05-27 | Moreira Carlos Chief Executive Officer | Sale 10b5-1 | −4,139 | $3.50 | $15K | 723,520 |
| 2026-05-14 | Buonanno Franck Jean Vice-President, Global Sales | Sale 10b5-1 | −20,000 | $2.90 | $58K | 10,000 |
| 2026-05-11 | Buonanno Franck Jean Vice-President, Global Sales | Option exercise 10b5-1 | +20,000 | $0.01 | $200 | 30,000 |
| 2026-05-11 | Buonanno Franck Jean Vice-President, Global Sales | Option exercise · Employee Stock Option Plan (right to buy) 10b5-1 | −20,000 | 0 | ||
| 2026-05-06 | Enguent Jean-Pierre Vice President, R&DSS | Sale 10b5-1 | −15,000 | $3.13 | $47K | 0 |
| 2026-05-04 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 | +15,000 | $0.01 | $150 | 15,000 |
| 2026-05-04 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise · Employee Stock Option Plan (right to buy) 10b5-1 | −15,000 | 15,000 | ||
| 2026-04-24 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −5,250 | $2.91 | $15K | 280,845 |
| 2026-04-23 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $2.88 | $29K | 286,095 |
| 2026-04-22 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $3.06 | $31K | 296,095 |
| 2026-04-21 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $3.04 | $30K | 306,095 |
| 2026-04-20 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $2.79 | $28K | 316,095 |
| 2026-04-17 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $2.72 | $27K | 326,095 |
| 2026-04-16 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $2.69 | $27K | 336,095 |
| 2026-04-13 | O'Hara John Charles Chief Financial Officer | Option exercise 10b5-1 | +130,500 | $0.01 | $1K | 346,095 |
| 2026-04-13 | O'Hara John Charles Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +130,500 | 130,500 | ||
| 2026-04-13 | O'Hara John Charles Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −130,500 | 0 | ||
| 2026-04-09 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $2.08 | $21K | 215,595 |
Page 3 of 5 · 82 trades